Abstract
In the present work, an attempt was made to develop and evaluate composite microspheres for controlled release of an anti-diabetic drug, nateglinide (NTG). The composite microspheres were prepared using rosin gum and ethyl cellulose as retardant polymers for drug release by solvent evaporation method. DSC and XRD analysis indicated the uniform dispersion of drug in the microspheres. The microspheres were capable of releasing drug for 24 h and the drug release mechanism followed non-Fickian transport. In vivo anti-diabetic activity conducted on wistar rats indicated that the plain (unformulated) NTG showed maximum percent reduction in blood glucose up to 2 h and then the blood glucose was increased. While in case of rats treated with test microspheres (RN6), the percent reduction in glucose level was slow up to 2 h as compared to plain drug, then it was gradually increased to 72.83 % at the end of 24 h. Histopathology of rat pancreas suggested that the regeneration of β cells was seen in the rats treated with RN6 microspheres. It can be concluded from the study that, the prepared microspheres are versatile delivery systems for nateglinide, which could release drug for longer period of time.
Keywords: Controlled release, ethyl cellulose, microspheres, nateglinide, rosin gum.
Drug Delivery Letters
Title:Composite Microspheres of Rosin Gum and Ethyl cellulose for Controlled Release of an Anti-diabetic Drug: in-vitro and in-vivo Assessment
Volume: 4 Issue: 3
Author(s): Kumari Niharika, Hanakunti M. Nanjappaiah, Akram A. Naikawadi and Raghavendra V. Kulkarni
Affiliation:
Keywords: Controlled release, ethyl cellulose, microspheres, nateglinide, rosin gum.
Abstract: In the present work, an attempt was made to develop and evaluate composite microspheres for controlled release of an anti-diabetic drug, nateglinide (NTG). The composite microspheres were prepared using rosin gum and ethyl cellulose as retardant polymers for drug release by solvent evaporation method. DSC and XRD analysis indicated the uniform dispersion of drug in the microspheres. The microspheres were capable of releasing drug for 24 h and the drug release mechanism followed non-Fickian transport. In vivo anti-diabetic activity conducted on wistar rats indicated that the plain (unformulated) NTG showed maximum percent reduction in blood glucose up to 2 h and then the blood glucose was increased. While in case of rats treated with test microspheres (RN6), the percent reduction in glucose level was slow up to 2 h as compared to plain drug, then it was gradually increased to 72.83 % at the end of 24 h. Histopathology of rat pancreas suggested that the regeneration of β cells was seen in the rats treated with RN6 microspheres. It can be concluded from the study that, the prepared microspheres are versatile delivery systems for nateglinide, which could release drug for longer period of time.
Export Options
About this article
Cite this article as:
Niharika Kumari, M. Nanjappaiah Hanakunti, A. Naikawadi Akram and V. Kulkarni Raghavendra, Composite Microspheres of Rosin Gum and Ethyl cellulose for Controlled Release of an Anti-diabetic Drug: in-vitro and in-vivo Assessment, Drug Delivery Letters 2014; 4 (3) . https://dx.doi.org/10.2174/2210303104666140909004015
DOI https://dx.doi.org/10.2174/2210303104666140909004015 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Current Medicinal Chemistry The Role and Predictive Value of Cytokines in Atherosclerosis and Coronary Artery Disease
Current Medicinal Chemistry Sympathetic Mechanisms of Hypoglycemic Counterregulation
Current Diabetes Reviews Genetic Lipodystrophies: Models for Insulin Resistance
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Radioprotective Effect of Gliclazide as an Anti-Hyperglycemic Agent Against Genotoxicity Induced by Ionizing Radiation on Human Lymphocytes
Cardiovascular & Hematological Agents in Medicinal Chemistry Secondary Prevention of Ischemic Stroke
Current Drug Targets Nicotinamide Supplementation Protects Gestational Diabetic Rats by Reducing Oxidative Stress and Enhancing Immune Responses
Current Medicinal Chemistry Current Concepts in the Management of Diabetic Polyneuropathy
Current Diabetes Reviews Analytical Procedures for Secondary Metabolites Determination: Recent Trends and Future Perspectives
Letters in Drug Design & Discovery Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?
Current Pharmaceutical Biotechnology Improved Insulin Resistance through Cajanus cajan extract in Gestational Diabetes Mellitus of Wistar Rat
Current Women`s Health Reviews Nonfasting Hyperlipidemia and Cardiovascular Disease
Current Drug Targets Can Nutrition Play a Role as a Stimulant for COVID 19 in Children?
Reviews on Recent Clinical Trials Contextualizing Genetics for Regional Heart Failure Care
Current Cardiology Reviews Patent Selections:
Recent Patents on Regenerative Medicine Pulmonary Pathology Among Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
Current Diabetes Reviews Micronized Purified Flavonoid Fraction (MPFF)*: A Review of its Pharmacological Effects, Therapeutic Efficacy and Benefits in the Management of Chronic Venous Insufficiency
Current Vascular Pharmacology Oxidative Stress in the Pathogenesis/Treatment of Atherosclerosis
Current Nutrition & Food Science Development of Mobile Tracking System for Diabetes and Recent Patents on Diabetes Mellitus
Recent Patents on Engineering